Literature DB >> 7923089

Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes.

J A Fletcher1, M C Gebhardt, H P Kozakewich.   

Abstract

Relatively few karyotypes have been reported from short-term cultures and/or direct harvests of osteosarcomas. We describe clonal aberrations in 17 high-grade osteosarcoma specimens and in one low-grade osteosarcoma. The high-grade osteosarcomas were karyotyped after direct harvest (four cases) or after short-term culture periods of < 1 week (13 cases). Three of these specimens, a primary osteosarcoma and two lung metastases, were from the same patient and shared a number of clonal aberrations. No consistent chromosome translocations were identified in the overall group of high-grade osteosarcomas, but potential nonrandom deletions involved 6q21-->qter, 9p21-->pter, chromosome 10, chromosome 13, 17p12-pter, and chromosome 20. Ring chromosomes were detected in three cases, and double-minute (dmin) chromosomes were detected in six. All high-grade osteosarcomas had numerous nonclonal chromosome aberrations superimposed on complex clonal events. The single low-grade osteosarcoma was characterized by a balanced, nonconstitutional, t(5;10) (p13;p14-15), together with an addition to the short arm of chromosome X. This is the first translocation reported in low-grade osteosarcoma, and the simplicity of the karyotype contrasts strikingly with those in the high-grade osteosarcomas.

Entities:  

Mesh:

Year:  1994        PMID: 7923089     DOI: 10.1016/0165-4608(94)90154-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

1.  Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.

Authors:  S F Huang; S Xiao; A A Renshaw; K R Loughlin; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

2.  Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors.

Authors:  D Gisselsson; T Jonson; A Petersén; B Strömbeck; P Dal Cin; M Höglund; F Mitelman; F Mertens; N Mandahl
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

3.  Osteosarcoma: mouse models, cell of origin and cancer stem cell.

Authors:  Maria V Guijarro
Journal:  Postdoc J       Date:  2014-02

4.  Establishment and characterization of OS 99-1, a cell line derived from a highly aggressive primary human osteosarcoma.

Authors:  Jennifer M Gillette; C Parker Gibbs; Sheila M Nielsen-Preiss
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-02-05       Impact factor: 2.416

5.  Aberrant DNA methylation of ESR1 and p14ARF genes could be useful as prognostic indicators in osteosarcoma.

Authors:  Viviane Sonaglio; Ana C de Carvalho; Silvia R C Toledo; Carolina Salinas-Souza; André L Carvalho; Antonio S Petrilli; Beatriz de Camargo; André L Vettore
Journal:  Onco Targets Ther       Date:  2013-06-17       Impact factor: 4.147

6.  miRNA Profiling: How to Bypass the Current Difficulties in the Diagnosis and Treatment of Sarcomas.

Authors:  Angélique Gougelet; Jennifer Perez; Daniel Pissaloux; Anthony Besse; Adeline Duc; Anne-Valérie Decouvelaere; Dominique Ranchere-Vince; Jean-Yves Blay; Laurent Alberti
Journal:  Sarcoma       Date:  2011-02-22

7.  Genetically engineered mouse models and human osteosarcoma.

Authors:  Alvin Jm Ng; Anthony J Mutsaers; Emma K Baker; Carl R Walkley
Journal:  Clin Sarcoma Res       Date:  2012-10-04

Review 8.  Animal models in osteosarcoma.

Authors:  Maria V Guijarro; Steven C Ghivizzani; C Parker Gibbs
Journal:  Front Oncol       Date:  2014-07-18       Impact factor: 6.244

9.  Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model.

Authors:  Yi Yang; Rui Yang; Michael Roth; Sajida Piperdi; Wendong Zhang; Howard Dorfman; Pulivarthi Rao; Amy Park; Sandeep Tripathi; Carrie Freeman; Yunjia Zhang; Rebecca Sowers; Jeremy Rosenblum; David Geller; Bang Hoang; Jonathan Gill; Richard Gorlick
Journal:  Genes Cancer       Date:  2017-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.